T2 Biosystems Gets FDA Clearance for Extended T2Bacteria Panel
Nonculture-Based T2Candida Test Reduces Time to Diagnosis in Septic Shock
HHS, Steven & Alexandra Cohen Foundation Award $2M to Lyme Disease Dx Projects
U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize
Sepsis being researched at Butler Memorial Hospital
T2 Biosystems Gets FDA 510(k) Clearance for Biothreat Panel
T2 Biosystems Gets FDA 510(k) Clearance for Biothreat Panel
T2 Biosystems’ Candida Auris Test Gets Breakthrough Device Designation
T2 Biosystems, Vanderbilt University Medical Center Partner on Prospective Bacterial Sepsis Dx Study
T2 Biosystems and VUMC partner to assess T2Bacteria Panel
T2 Biosystems seeking FDA breakthrough device designation for Candida auris test
How T2 Biosystems Inc. is utilizing miniaturized magnetic resonance technology for Lyme Disease
